{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:40:01Z","timestamp":1782517201818,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jaad.2003.12.016","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T05:21:14Z","timestamp":1082956874000},"page":"783-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma"],"prefix":"10.1016","volume":"50","author":[{"given":"Regina","family":"Treudler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Georgieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph C","family":"Geilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin E","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2003.12.016_BIB1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1054\/bjoc.2001.1731","article-title":"Dacarbazine and interferon alfa with or without interleukin 2 in metastatic melanoma","volume":"84","author":"Hauschild","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2003.12.016_BIB2","unstructured":"Ippen H. [Light-caused skin reaction in dacarbazine therapy.] Dtsch Med Wochenschr 1980;105:531. German"},{"key":"10.1016\/j.jaad.2003.12.016_BIB3","first-page":"588","article-title":"First case of urticaria due to dacarbazine","volume":"50","author":"Bourry","year":"1995","journal-title":"Therapie"},{"key":"10.1016\/j.jaad.2003.12.016_BIB4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/mpo.2950160605","article-title":"Procarbazine hypersensitivity manifested as a fixed drug eruption","volume":"16","author":"Giguere","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaad.2003.12.016_BIB5","first-page":"470","article-title":"Radiation recall dermatitis in a patient treated with dacarbazine","volume":"13","author":"Kennedy","year":"2001","journal-title":"Clin Oncol"},{"key":"10.1016\/j.jaad.2003.12.016_BIB6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0731-7085(00)00466-0","article-title":"High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma","volume":"24","author":"Kim","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jaad.2003.12.016_BIB7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ajhp\/59.14.1351","article-title":"Stability of dacarbazine in amber glass vials and polyvinyl chloride bags","volume":"59","author":"Aatmani","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2003.12.016_BIB8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1211\/002235702320266280","article-title":"Causative agent of vascular pain among photodegradation products of dacarbazine","volume":"54","author":"Asahi","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jaad.2003.12.016_BIB9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00105-002-0407-z","article-title":"Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis","volume":"53","author":"Frick","year":"2002","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2003.12.016_BIB10","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1200\/JCO.2003.10.039","article-title":"Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma","volume":"21","author":"Danson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2003.12.016_BIB11","first-page":"5846","article-title":"Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo","volume":"47","author":"Stevens","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2003.12.016_BIB12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00688855","article-title":"Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide","volume":"27","author":"Tsang","year":"1991","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:31:32Z","timestamp":1759267892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0190962204002610"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2003.12.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2003.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}